Showing results (11-20 of 170) with videos related to
Sort By:
Pageof 17
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 15, 2000
Docetaxel (Taxotere) in the treatment of non-small cell lung cancer (NSCLC)--is there a role for a new chemotherapy programme?J P ArmandAnti-Cancer Drugs|August 1, 1996
The clinical rationale for developing docetaxel (Taxotere)J P ArmandEuropean Journal of Cancer (Oxford, England : 1990)|July 8, 2000
A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinomaP Rougier, A Adenis, M Ducreux, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracilP Wibault, M A Bensmaine, M de Forni, et al.Bulletin Du Cancer|February 5, 1999
[Irinotecan-containing combinations in solid tumors, except colonic carcinomas]C Couteau, J P ArmandEuropean Journal of Cancer (Oxford, England : 1990)|August 19, 2004
Procarbazine in haematology: an old drug with a new life?M Massoud, J P Armand, V RibragThe Journal of Infusional Chemotherapy|July 1, 1996
CPT-11: the European clinical developmentC Terret, C Couteau, J P ArmandDrugs|December 29, 2000
Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapyE Raymond, S Faivre, J P ArmandTherapie|November 7, 1998
[Recommendations for the study of drug combination therapy for the treatment of AIDS and cancer. Round Table No 7 at Giens XIII]J P Armand, J Dormont, A SchwebigPageof 17